Outcomes | Number of studies | Sample size | Heterogeneity (P, I2) | Overall effect size | 95% CI of overall effect | P | |
---|---|---|---|---|---|---|---|
 |  | LAP | OPEN |  |  |  |  |
Operation time (min) | 13 | 371 | 377 | <0.001, 81% | WMD = -1.06 | -16.93, 14.81 | 0.90 |
Blood loss (ml) | 11 | 300 | 302 | <0.001, 71% | WMD = -58.20 | -81.76, -34.65 | <0.01 |
Time to first flatus (d) | 6 | 129 | 142 | 0.09, 47% | WMD = -1.28 | -1.60, -0.97 | <0.01 |
Time to oral intake (d) | 7 | 212 | 241 | 0.02, 61% | WMD = -1.77 | -2.18, -1.35 | <0.01 |
Hospital stay (d) | 11 | 309 | 339 | 0.006, 60% | WMD = -2.87 | -3.54, -2.21 | <0.01 |
Overall complications | 12 | 341 | 345 | 0.74, 0% | RR = 0.49 | 0.30, 0.81 | <0.01 |
Tumor size (cm) | 13 | 371 | 377 | 0.23, 21% | WMD = -0.57 | -0.86, -0.29 | <0.01 |
Recurrence | 8 | 248 | 232 | 0.81, 0% | RR = 0.66 | 0.31, 1.42 | 0.29 |